Abstract
The purpose of this paper is to examine the sets of model and literature review to prove that strategy of applying free chemical usage in purified water system for pharmaceutical industry would be help the existing and new pharmaceutical companies to comply with part of Natioanal Agency of Drug and Food Control / Badan Pengawas Obat dan Makanan (NADFC/BPOM) regulation in order to achieve Cara Pembuatan Obat yang Baik (CPOB) of Indonesia pharmaceutical industry. One of the main reasons is when we figured out the number of Indonesian pharmaceutical industries in 2012 are kept reducing compare to the increasing numbers of Indonesian population growth. This strategy concept also might help the industries to reducing environmental pollution, and operational cost in pharmaceutical industries, by reducing of the chemical usage for water treatment process in floculation and cougulation and chlorination for sterillization. This new model is free usage of chemicals for purified water generation system process and sterilization. The concept offering of using membrane technology- Reverse Osmosis (RO) membrane base treatment to replace traditional chemical base treatment, following enhance Electrodeionization (EDI) as final polisher for controlling conductivity, and finally Ultra Violet (UV) disinfectant technology as final guard for bacteria controls instead of chemical base system in purified water generation system.
Highlights
As the world fourth largest population country, the numbers of population in Indonesia is estimated around 220 millions, with an annual growth rate of 1.5% per annum (International Trade Centre, 2005)
There should be huge potential market for pharmaceutical industry to growth in Indonesia when we compare the numbers of population and the numbers of pharmaceutical company but the fact is the other way round
This sysem is comply with Cara Pembuatan Obat yang Baik” (CPOB) (Cara Pembuatan Obat yang Baik) in Indonesia, we will be further elaborate this system become an complete integrated system for a new model to applying in purified water system for pharmaceutical industry
Summary
As the world fourth largest population country, the numbers of population in Indonesia is estimated around 220 millions, with an annual growth rate of 1.5% per annum (International Trade Centre, 2005). While, based on Gabungan Perusahaan Farmasi (Indonesian Association of Pharmaceutical Companies), the numbers of pharmaceutical company keep decreasing from year to year. There should be huge potential market for pharmaceutical industry to growth in Indonesia when we compare the numbers of population and the numbers of pharmaceutical company but the fact is the other way round. Based on the Business Monitor International (2010) report, the main regulatory in Indonesia pharmaceutical industry is the government-controlled National Agency of Drug and Food Control / Badan Pengawas Obat dan Makanan (NADFC/BPOM). The agency was created in 2001 as a part of a major restructuring of the regulatory system. It has broader authority than its predecessor, and reports directly to the president. BPOM claims to prioritize accelerating the drug approval process and improving transparency
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
